Abstract
This article provides updates in the fields of device therapy for ventricular arrhythmias—including risk stratification regarding patient selection for implantable cardioverter defibrillators, the optimal programming for implantable cardioverter defibrillators to reduce inappropriate shocks, the impact of sports participation on patients with implantable cardioverter defibrillators, and the future of resynchronization therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
